greeksoup/ stock research

Dentsply Sirona (XRAY) FY2023 results: revenue $4.0 billion, up 1.1% on the year

Dentsply Sirona Inc. (XRAY) reported revenue of $4.0 billion for fiscal 2023, the year ended 31 December 2023, up 1.1% on the year before. Net income was -$132 million, and diluted earnings per share $-0.62. The figures are the company's own, from the 10-K it filed with the SEC on 29 February 2024.

Revenue
$4.0 billion
+1.1% on the year
FY2016FY2023
Operating margin
-2.1%
-23.9% a year earlier
FY2016FY2023
Net income
-$132 million
FY2016FY2023
Diluted EPS
-$0.62
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue3,9653,9224,231+1.1%
Cost of revenue1,8791,7951,884+4.7%
Gross profit2,0862,1272,347-1.9%
Gross margin52.6%54.2%55.5%
Research and development184174171+5.7%
Selling, general and administrative1,6131,5891,551+1.5%
Operating income-85.0-937608
Operating margin-2.1%-23.9%14.4%
Interest expense81.065.061.0+24.6%
Pre-tax income-175-1,055545
Income tax-43.0-105134
Effective tax raten/an/a24.6%
Net income-132-950411
Net margin-3.3%-24.2%9.7%
Diluted EPS-$0.62-$4.41$1.87
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow377517657-27.1%
Capital expenditure1491491420.0%
Free cash flow228368515-38.0%
Free cash flow margin5.8%9.4%12.2%
Cash from investing-89.0-138-358
Cash from financing-307-329-379
Depreciation and amortisation343328347+4.6%
Share-based compensation46.059.048.0-22.0%
Buybacks300150200+100.0%
Dividends paid11610492.0+11.5%
Dividend per share$0.56$0.50$0.43+12.0%
Diluted shares, weighted212m216m220m-1.6%
Shares outstanding at period end207m215m217m-3.8%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity3,2933,8114,996-13.6%
Non-controlling interest1.01.01.00.0%
Debt2,1181,9442,095+9.0%
Operating lease liabilities125149149-16.1%
Finance lease liabilities1.01.01.00.0%
Other liabilities1,8321,7371,997+5.5%
Total liabilities and equity7,3707,6439,239-3.6%
Fixed assets800761773+5.1%
Goodwill2,4382,6883,976-9.3%
Intangible assets1,7051,9032,319-10.4%
Cash and equivalents334365339-8.5%
Inventory624627515-0.5%
Other assets1,4691,2991,317+13.1%
Total assets7,3707,6439,239-3.6%

10-K for the year ended 31 December 2023, filed 29 February 2024: the filing.